Pacira Biosciences, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pacira Biosciences, Inc. on June 11, 2021, covering events that occurred on June 8, 2021. The report details the outcomes of the Company's 2021 Annual Meeting of Stockholders, which was conducted as a virtual meeting via live audio webcast.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and stockholder voting results.
Material Changes and Voting Results
Stockholders approved four key proposals at the Annual Meeting:
- Proposal 1 (Election of Directors): Three Class I directors were elected to serve until the 2024 Annual Meeting.
- Laura Brege: 37,811,917 votes For; 1,498,274 Withheld.
- Mark Froimson: 39,035,093 votes For; 275,098 Withheld.
- Mark Kronenfeld: 38,817,454 votes For; 492,737 Withheld.
- Proposal 2 (Auditor Ratification): Stockholders ratified the appointment of KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021 (41,497,945 For; 18,455 Against).
- Proposal 3 (Executive Compensation): An advisory vote to approve the compensation of named executive officers was approved (35,140,873 For; 4,152,964 Against).
- Proposal 4 (Stock Incentive Plan): Stockholders approved the Amended and Restated 2011 Stock Incentive Plan. This amendment increases the number of shares of common stock authorized for grant by 1,500,000 newly reserved shares. The plan became effective immediately upon approval (23,619,009 For; 15,568,879 Against).
Guidance, Outlook, and Risks
The filing does not provide management guidance, financial outlook, or discuss specific risks or contingencies beyond the standard incorporation of the Stock Incentive Plan text by reference.
Key Facts for Investor Verification
- Verify the impact of the 1,500,000 share increase in the Amended and Restated 2011 Stock Incentive Plan on potential future dilution.
- Note the significant number of "Against" votes (15,568,879) on the Stock Incentive Plan proposal, indicating notable stockholder dissent on this specific matter.
- Confirm the tenure of the newly elected Class I directors, which extends until the 2024 Annual Meeting.
- Review the full text of the Amended and Restated 2011 Stock Incentive Plan filed as Exhibit 10.1 for detailed terms.